Synthesis of and chemotactic responses elicited by fMet-Leu-Phe analogs containing difluoro- and trifluoromethionine

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 23, 1997, Pages 3007-3012

  Houston Jr , Michael E ^a,c   Harvath, Liana ^b   Honek, John F ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; METHIONINE DERIVATIVE; ORGANOFLUORINE DERIVATIVE; TRIPEPTIDE;

ARTICLE; CALCULATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR DYNAMICS; NEUTROPHIL; NORMAL HUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

EID: 0342710329     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10134-2     Document Type: Article

References (25)

1. Gellman, S. H. Biochemistry 1991, 30, 6633.
2. Viguera, A. R.; Serrano, L. Biochemistry 1995, 34, 8771.
3. Duewel, H.; Daub, E.; Robinson, V.; Honek, J. F. Biochemistry 1997, 36, 3404.
4. (a) Harvath, L. Annu. Rep. Med. Chem. 1989, 24, 233.
5. (b) Kalmar, J. R.; Van Dyke, T. E. Methods Enzymol. 1994, 236B, 58.
6. (a) Derian, C. K.; Solomon, H. F.; Higgins III, J. D.; Beblavy, M. J.; Santulli, R. J.; Bridger, G. J.; Pike, M. C.; Kroon, D. J.; Fischman, A. J. Biochemistry 1996, 35, 1265.
7. (b) Fischman, A. J.; Rauh, D.; Solomon, H.; Babich, J. W.; Tompkins, R. G.; Kroon, D.; Strauss, H. W.; Rubin, R. H. J. Nucl. Med. 1993, 34, 2130.
8. (a) Higgins III, J. D.; Bridger, G. J.; Derian, C. K.; Beblavy, M. J.; Hernandez, P. E.; Gaul, F. E.; Abrams, M. J.; Pike, M. C.; Solomon, H. F. J. Med. Chem. 1996, 39, 1013.
9. (b) Dentino, A. R.; Raj, P. A.; Bhandary, K. K.; Wilson, M. E.; Levine, M. J. J. Biol. Chem. 1991, 266, 18460.
10. (c) Vertuani, G.; Spisani, S.; Boggian, M.; Traniello, S.; Scatturin, A. Int. J. Pept. Prot. Res. 1987, 29, 525.
11. (a) Freer, R. J.; Day, A. R.; Radding, J. A.; Schiffmann, E.; Aswanikumar, S.; Showell, H. J.; Becker, E. L. Biochemistry 1980, 19, 2404.
12. (b) Fruchtmann, R.; Kreisfeld, K.; Marowski, C.; Opitz, W. Hoppe-Seyler's Z. Physiol. Chem. 1981, 362, 163.
13. (c) Freer, R. J.; Day, A. R.; Muthukumaraswamy, N.; Pinon, D.; Wu, A.; Showell, H. J.; Becker, E. L. Biochemistry 1982, 21, 257.
14. Harvath, L.; Aksamit, R. R. J. Immunol. 1984, 133, 1471.
15. Houston, M. E.; Honek, J. F. J. Chem. Soc., Chem. Commun. 1989, 761.
16. Ryakhovskii, V. V.; Agafonov, S. V.; Vinogradova, O. B.; Kosyrev, Yu. M.; Kiselevskii, M. V.; Dobryanskii, V. S. Khimiko-Farmatsevticheskii Zhurnal 1992, 26, 46 (Chem. Abstr. 117:172064z).
17. Ryakhovskii, V. V.; Agafonov, S. V.; Vinogradova, O. B.; Kosyrev, Yu. M.; Kiselevskii, M. V.; Dobryanskii, V. S. Khimiko-Farmatsevticheskii Zhurnal 1992, 26, 46 (Chem. Abstr. 117:172064z).
18. Prepared by DCC/HOBT coupling of Boc-L-Leu and L-Phe-OMe followed by acid deprotection.
19. Lajoie, G.; Kraus, J. L. Peptides 1984, 5, 653.
20. +). Final compounds were purified to homogeneity by HPLC (Vydac SB-C8; linear gradient: water/0.02% TFA to acetonitrile/0.02% TFA). All compounds were homogeneous under a variety of TLC and HPLC conditions and had spectroscopic and mass analysis in agreement with the assigned structures.
21. Falk, W.; Goodwin, R. H.; Leonard, E. J. J. Immunol. Methods 1980, 33, 239.
22. Log P values were calculated using the atomic parameters reported by Viswanadhan, V. N.; Ghose, A. K.; Revankar, G. R.; Robins, R. K. J. Chem. Inf. Comput. Sci. 1989, 29, 163 as implemented in ChemPlus (Hypercube Inc., Gainesville, FL).
23. Fay, S. P.; Domalewski, M. D.; Sklar, L. A. Biochemistry 1993, 32, 1627.
24. Ab initio geometry optimizations and electrostatic potential mapped onto electron density isosurfaces were calculated using the program PC SPARTAN (Wavefunction Inc., Irvine CA). Atomic charges fit to electrostatic potentials were performed in PC SPARTAN and are based on the following methods: Chirlian, L. E.; Francl, M. J. Computational Chem. 1987, 8, 894; Breneman, C. M.; Wiberg, K. B. J. Computational Chem. 1990, 11, 361.
25. Ab initio geometry optimizations and electrostatic potential mapped onto electron density isosurfaces were calculated using the program PC SPARTAN (Wavefunction Inc., Irvine CA). Atomic charges fit to electrostatic potentials were performed in PC SPARTAN and are based on the following methods: Chirlian, L. E.; Francl, M. J. Computational Chem. 1987, 8, 894; Breneman, C. M.; Wiberg, K. B. J. Computational Chem. 1990, 11, 361.